{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T20:04:34Z","timestamp":1789243474540,"version":"build-2803163510"},"reference-count":30,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T00:00:00Z","timestamp":1718928000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Japan Agency for Medical Research and Development","award":["JP24fk0210123"],"award-info":[{"award-number":["JP24fk0210123"]}]},{"name":"Japan Agency for Medical Research and Development","award":["JP24fk0210113"],"award-info":[{"award-number":["JP24fk0210113"]}]},{"name":"Japan Agency for Medical Research and Development","award":["JP24fk0210111"],"award-info":[{"award-number":["JP24fk0210111"]}]},{"name":"Japan Agency for Medical Research and Development","award":["JP24fk0210104"],"award-info":[{"award-number":["JP24fk0210104"]}]},{"name":"Japan Agency for Medical Research and Development","award":["JP24fk0210126"],"award-info":[{"award-number":["JP24fk0210126"]}]},{"name":"Japan Agency for Medical Research and Development","award":["23HC2003"],"award-info":[{"award-number":["23HC2003"]}]},{"name":"Japan Agency for Medical Research and Development","award":["23HC2002"],"award-info":[{"award-number":["23HC2002"]}]},{"name":"Japan Agency for Medical Research and Development","award":["23HC2001"],"award-info":[{"award-number":["23HC2001"]}]},{"name":"Japanese Ministry of Health, Labor and Welfare","award":["JP24fk0210123"],"award-info":[{"award-number":["JP24fk0210123"]}]},{"name":"Japanese Ministry of Health, Labor and Welfare","award":["JP24fk0210113"],"award-info":[{"award-number":["JP24fk0210113"]}]},{"name":"Japanese Ministry of Health, Labor and Welfare","award":["JP24fk0210111"],"award-info":[{"award-number":["JP24fk0210111"]}]},{"name":"Japanese Ministry of Health, Labor and Welfare","award":["JP24fk0210104"],"award-info":[{"award-number":["JP24fk0210104"]}]},{"name":"Japanese Ministry of Health, Labor and Welfare","award":["JP24fk0210126"],"award-info":[{"award-number":["JP24fk0210126"]}]},{"name":"Japanese Ministry of Health, Labor and Welfare","award":["23HC2003"],"award-info":[{"award-number":["23HC2003"]}]},{"name":"Japanese Ministry of Health, Labor and Welfare","award":["23HC2002"],"award-info":[{"award-number":["23HC2002"]}]},{"name":"Japanese Ministry of Health, Labor and Welfare","award":["23HC2001"],"award-info":[{"award-number":["23HC2001"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Background and aims: The enhanced liver fibrosis (ELF) score is a blood test that combines three markers linked to liver fibrosis. The utility of the ELF score has been demonstrated primarily in Western countries, but whether it is useful in areas with a high number of elderly people suffering from chronic liver disease has yet to be determined. Methods: This is a prospective study that included 373 consecutive patients who underwent a liver biopsy and had their ELF score measured on the same day. The diagnostic accuracy of the ELF score for liver fibrosis and the effect of age on the ELF score were investigated. Results: The median (interquartile) ELF scores in F0, F1, F2, F3, and F4 are 8.7 (8.2\u20139.2), 9.3 (8.8\u201310.0), 10.1 (9.4\u201310.7), 10.7 (9.9\u201311.2), and 12.0 (11.2\u201312.7), respectively. ELF scores increased with increasing liver fibrosis stage (p &lt; 0.001). The diagnostic accuracy of the ELF score and FIB-4 for significant fibrosis (F2\u20134) and advanced fibrosis (F3\u20134) was comparable, but the ELF score had a higher diagnostic accuracy for cirrhosis (F4) than FIB-4. When patients were stratified by age of 60 years, the median ELF score did not differ by age in F2, F3, and F4. However, the median FIB-4 increased in patients with \u226560 years compared to those with &lt;60 years in all fibrosis stages. Conclusions: ELF score has high diagnostic accuracy for liver fibrosis, regardless of age, and it could be used as a primary screening method.<\/jats:p>","DOI":"10.3390\/diagnostics14131317","type":"journal-article","created":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T05:33:28Z","timestamp":1718948008000},"page":"1317","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Enhanced Liver Fibrosis Score for Diagnosing Liver Fibrosis in Chronic Hepatitis"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4634-6616","authenticated-orcid":false,"given":"Nobuharu","family":"Tamaki","sequence":"first","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Tokyo 180-8610, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2644-8084","authenticated-orcid":false,"given":"Kenta","family":"Takaura","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Tokyo 180-8610, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayu","family":"Higuchi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Tokyo 180-8610, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6117-4990","authenticated-orcid":false,"given":"Yutaka","family":"Yasui","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Tokyo 180-8610, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Itakura","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Tokyo 180-8610, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaoru","family":"Tsuchiya","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Tokyo 180-8610, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Nakanishi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Tokyo 180-8610, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Namiki","family":"Izumi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Tokyo 180-8610, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Kurosaki","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Tokyo 180-8610, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,6,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/apt.16745","article-title":"Longitudinal association of magnetic resonance elastography-associated liver stiffness with complications and mortality","volume":"55","author":"Higuchi","year":"2022","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/s41575-023-00760-9","article-title":"Global burden of hepatitis B virus: Current status, missed opportunities and a call for action","volume":"20","author":"Hsu","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Pham, Y.T., Huang, D.Q., Zhang, Z., Ng, C.H., Tan, D.J.H., Nguyen, H.C., Nguyen, T.C., Behari, J., Yuan, J.M., and Luu, H.N. (2024). Changing global epidemiology of chronic hepatitis C virus-related outcomes from 2010 to 2019: Cirrhosis is the growing burden of hepatitis C virus-related disease. Eur. J. Cancer Prev., Online ahead of print.","DOI":"10.1097\/CEJ.0000000000000885"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/hep.29085","article-title":"Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis","volume":"65","author":"Dulai","year":"2017","journal-title":"Hepatology"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1097\/HEP.0000000000000470","article-title":"Magnetic resonance elastography-based prediction model for hepatic decompensation in NAFLD: A multicenter cohort study","volume":"78","author":"Kim","year":"2023","journal-title":"Hepatology"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.cgh.2021.07.021","article-title":"Risk Difference of Liver-Related and Cardiovascular Events by Liver Fibrosis Status in Nonalcoholic Fatty Liver Disease","volume":"20","author":"Tamaki","year":"2022","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1056\/NEJM200102153440706","article-title":"Liver biopsy","volume":"344","author":"Bravo","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1053\/j.gastro.2018.12.036","article-title":"Noninvasive Assessment of Liver Disease in Patients with Nonalcoholic Fatty Liver Disease","volume":"156","author":"Castera","year":"2019","journal-title":"Gastroenterology"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41574-021-00584-0","article-title":"Non-invasive methods for imaging hepatic steatosis and their clinical importance in NAFLD","volume":"18","author":"Tamaki","year":"2022","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/hepr.13764","article-title":"Noninvasive assessment of liver fibrosis and its clinical significance in nonalcoholic fatty liver disease","volume":"52","author":"Tamaki","year":"2022","journal-title":"Hepatol. Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.cgh.2022.01.023","article-title":"Two-Step Strategy, FIB-4 Followed by Magnetic Resonance Elastography, for Detecting Advanced Fibrosis in NAFLD","volume":"21","author":"Tamaki","year":"2023","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jhep.2013.03.016","article-title":"The Enhanced Liver Fibrosis (ELF) score: Normal values, influence factors and proposed cut-off values","volume":"59","author":"Lichtinghagen","year":"2013","journal-title":"J. Hepatol."},{"key":"ref_14","first-page":"78","article-title":"Possibility of Using ELF Score as Index for Hepatic Fibrosis Evaluation","volume":"63","author":"Asano","year":"2015","journal-title":"Rinsho Byori"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jhep.2023.04.002","article-title":"Using the ELF test, FIB-4 and NAFLD fibrosis score to screen the population for liver disease","volume":"79","author":"Kjaergaard","year":"2023","journal-title":"J. Hepatol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.cgh.2020.06.070","article-title":"Enhanced Liver Fibrosis Score Can Be Used to Predict Liver-Related Events in Patients with Nonalcoholic Steatohepatitis and Compensated Cirrhosis","volume":"19","author":"Are","year":"2021","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/hepr.13871","article-title":"Diagnostic accuracy of enhanced liver fibrosis test for nonalcoholic steatohepatitis-related fibrosis: Multicenter study","volume":"53","author":"Seko","year":"2023","journal-title":"Hepatol. Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1111\/hepr.13495","article-title":"Accuracy of the Enhanced Liver Fibrosis test, and combination of the Enhanced Liver Fibrosis and non-invasive tests for the diagnosis of advanced liver fibrosis in patients with non-alcoholic fatty liver disease","volume":"50","author":"Inadomi","year":"2020","journal-title":"Hepatol. Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/hep.21669","article-title":"FIB-4: An inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest","volume":"46","author":"Mallet","year":"2007","journal-title":"Hepatology"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e3349","DOI":"10.1093\/cid\/ciaa1307","article-title":"Change in Fibrosis 4 Index as Predictor of High Risk of Incident Hepatocellular Carcinoma After Eradication of Hepatitis C Virus","volume":"73","author":"Tamaki","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","article-title":"AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease","volume":"77","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"European Association for the Study of The Liver, and European Association for the Study of Diabetes (2016). EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J. Hepatol., 64, 1388\u20131402.","DOI":"10.1016\/j.jhep.2015.11.004"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.cgh.2023.11.022","article-title":"Accuracy of the Enhanced Liver Fibrosis Test in Patients With Type 2 Diabetes Mellitus and Its Clinical Implications","volume":"22","author":"Arai","year":"2024","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e27403","DOI":"10.1097\/MD.0000000000027403","article-title":"Enhanced liver fibrosis score as a surrogate of liver-related complications and mortality in primary biliary cholangitis","volume":"100","author":"Fujinaga","year":"2021","journal-title":"Medicine"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3892\/mco.2021.2377","article-title":"Enhanced liver fibrosis score as a predictive marker for hepatocellular carcinoma development after hepatitis C virus eradication","volume":"15","author":"Kawaguchi","year":"2021","journal-title":"Mol. Clin. Oncol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s00535-021-01796-x","article-title":"Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis 2020","volume":"56","author":"Tokushige","year":"2021","journal-title":"J. Gastroenterol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1007\/s00535-018-1474-y","article-title":"The novel cutoff points for the FIB4 index categorized by age increase the diagnostic accuracy in NAFLD: A multi-center study","volume":"53","author":"Ishiba","year":"2018","journal-title":"J. Gastroenterol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"10109","DOI":"10.1038\/s41598-019-46172-1","article-title":"Wisteria floribunda agglutinin-positive mac-2 binding protein as an age-independent fibrosis marker in nonalcoholic fatty liver disease","volume":"9","author":"Tamaki","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"101011","DOI":"10.1016\/j.jhepr.2024.101011","article-title":"Impact of age on NIS2+\u2122 and other non-invasive blood tests for the evaluation of liver disease and detection of at-risk MASH","volume":"6","author":"Anstee","year":"2024","journal-title":"JHEP Rep."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"6493","DOI":"10.21037\/qims-23-511","article-title":"Detecting advanced liver fibrosis using ultrasound shear wave velocity measurement in the general population","volume":"13","author":"Kirino","year":"2023","journal-title":"Quant. Imaging Med. Surg."}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/14\/13\/1317\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:02:10Z","timestamp":1760108530000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/14\/13\/1317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,21]]},"references-count":30,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2024,7]]}},"alternative-id":["diagnostics14131317"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics14131317","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,21]]}}}